Page 260 - Pagetit
P. 260

7. ETHICAL ISSUES IN NEUROSCIENCE RESEARCH ON SUBSTANCE DEPENDENCE TREATMENT AND PREVENTION



                     Mann JM (1999) Medicine and public health, ethics and human rights. In: Mann
                     JM et al., eds. Health and human rights: a reader. London, Routledge:439–452.
                     Mann JM et al. (1999) Health and human rights. In: Mann JM et al., eds. Health
                     and human rights: a reader. London, Routledge:7–20.
                     Martin-Soelch C et al. (2001) Reward mechanisms in the brain and their role in
                     dependence: evidence from neurophysiological and neuroimaging studies. Brain
                     Research Reviews, 36:139–149.
                     Mora F (2000) The brain and the mind. In: Gelder MG, Lopez-Ibor JJ, eds. The
                     new Oxford textbook of psychiatry. Oxford, Oxford University Press:153–157.
                     Naquet R (1993) Ethical and moral considerations in the design of experiments.
                     Neuroscience, 57:183–189.
                     National Academy of Science (1996) Pathways of addiction: opportunities in drug
                     abuse research. Washington, DC, National Academy Press.

                     National Bioethics Advisory Commission (1999) Research involving persons with
                     mental disorders that may affect decision-making capacity. Rockville, MD,
                     National Bioethics Advisory Commission.
                     National Research Council (2001) Informing America’s policy on illegal drugs: what
                     we don’t know keeps hurting us. Washington, DC, National Academy Press.
                     Nelkin D, Lindee MS (1996) “Genes made me do it”: the appeal of biological
                     explanations. Politics and Life Sciences, 15:95–97.
                     Nestler EJ (2000) Genes and addiction. Nature Genetics, 26:277–281.

                     Platt JJ (1997) Cocaine addiction: theory, research, and treatment. Cambridge, MA,
                     Harvard University Press.
                     Porter L, Arif AE, Curran WJ (1986) The law and the treatment of drug- and alcohol-
                     dependent persons: a comparative study of existing legislation. Geneva, World
                     Health Organization.
                     Preuss TM (2000) Taking the measure of diversity: comparative alternatives to
                     the model-animal paradigm in cortical neuroscience. Brain Behavior and
                     Evolution, 55:287–299.
                     Reidenberg MM (2001) Releasing the grip of big pharma. Lancet, 358:664.
                     Resnik DB (1998) The ethics of science: an introduction. London, Routledge.
                     Roberts LW, Roberts B (1999) Psychiatric research ethics: an overview of evolving
                     guidelines and current ethical dilemmas in the study of mental illness. Biological
                     Psychiatry, 46:1025–1038.
                     Sell LA et al. (1999) Activation of reward circuitry in human opiate addicts.
                     European Journal of Neuroscience, 11:1042–1048.
                     Shamoo AE (1998) Ethics in neurobiological research with human subjects: the
                     Baltimore Conference on Ethics. Amsterdam, Gordon & Breach.
                     Spooner C, Hall W (2002) Preventing substance misuse among young people: we
                     need to do more than “just say no”. Addiction, 97:478-481.
                     Spooner C et al. (2001) An overview of diversion strategies for drug-related
                     offenders. Drug and Alcohol Review, 20:281–294.


                                                     239




          Chapter_7                239                             19.1.2004, 11:51
   255   256   257   258   259   260   261   262   263   264   265